These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31687320)

  • 1. Enhanced blood-brain-barrier penetrability and tumor-targeting efficiency by peptide-functionalized poly(amidoamine) dendrimer for the therapy of gliomas.
    Liu C; Zhao Z; Gao H; Rostami I; You Q; Jia X; Wang C; Zhu L; Yang Y
    Nanotheranostics; 2019; 3(4):311-330. PubMed ID: 31687320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel synergetic targeting strategy for glioma therapy employing borneol combination with angiopep-2-modified, DOX-loaded PAMAM dendrimer.
    Han S; Zheng H; Lu Y; Sun Y; Huang A; Fei W; Shi X; Xu X; Li J; Li F
    J Drug Target; 2018 Jan; 26(1):86-94. PubMed ID: 28635335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas.
    Li Y; He H; Jia X; Lu WL; Lou J; Wei Y
    Biomaterials; 2012 May; 33(15):3899-908. PubMed ID: 22364698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted delivery of methotrexate to epidermal growth factor receptor-positive brain tumors by means of cetuximab (IMC-C225) dendrimer bioconjugates.
    Wu G; Barth RF; Yang W; Kawabata S; Zhang L; Green-Church K
    Mol Cancer Ther; 2006 Jan; 5(1):52-9. PubMed ID: 16432162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
    Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W
    J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PEGylated Polyamidoamine dendrimer conjugated with tumor homing peptide as a potential targeted delivery system for glioma.
    Jiang Y; Lv L; Shi H; Hua Y; Lv W; Wang X; Xin H; Xu Q
    Colloids Surf B Biointerfaces; 2016 Nov; 147():242-249. PubMed ID: 27518456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma.
    Xin H; Jiang X; Gu J; Sha X; Chen L; Law K; Chen Y; Wang X; Jiang Y; Fang X
    Biomaterials; 2011 Jun; 32(18):4293-305. PubMed ID: 21427009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma.
    Di Mauro PP; Cascante A; Brugada Vilà P; Gómez-Vallejo V; Llop J; Borrós S
    Int J Pharm; 2018 Dec; 553(1-2):169-185. PubMed ID: 30321641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glioma Dual-Targeting Nanohybrid Protein Toxin Constructed by Intein-Mediated Site-Specific Ligation for Multistage Booster Delivery.
    Chen Y; Zhang M; Jin H; Li D; Xu F; Wu A; Wang J; Huang Y
    Theranostics; 2017; 7(14):3489-3503. PubMed ID: 28912890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel doxorubicin loaded folic acid conjugated PAMAM modified with borneol, a nature dual-functional product of reducing PAMAM toxicity and boosting BBB penetration.
    Xu X; Li J; Han S; Tao C; Fang L; Sun Y; Zhu J; Liang Z; Li F
    Eur J Pharm Sci; 2016 Jun; 88():178-90. PubMed ID: 26965003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PEGylated Poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors.
    He H; Li Y; Jia XR; Du J; Ying X; Lu WL; Lou JN; Wei Y
    Biomaterials; 2011 Jan; 32(2):478-87. PubMed ID: 20934215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Angiopep-modified doxorubicin (ANG1007) and etoposide (ANG1009) chemotherapeutics with increased brain penetration.
    Ché C; Yang G; Thiot C; Lacoste MC; Currie JC; Demeule M; Régina A; Béliveau R; Castaigne JP
    J Med Chem; 2010 Apr; 53(7):2814-24. PubMed ID: 20210346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer.
    Ke W; Shao K; Huang R; Han L; Liu Y; Li J; Kuang Y; Ye L; Lou J; Jiang C
    Biomaterials; 2009 Dec; 30(36):6976-85. PubMed ID: 19765819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Dual Receptor Targeting- and BBB Penetrating- Peptide Functionalized Polyethyleneimine Nanocomplex for Secretory Endostatin Gene Delivery to Malignant Glioma.
    Lu L; Chen H; Wang L; Zhao L; Cheng Y; Wang A; Wang F; Zhang X
    Int J Nanomedicine; 2020; 15():8875-8892. PubMed ID: 33209022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma.
    Zhang B; Sun X; Mei H; Wang Y; Liao Z; Chen J; Zhang Q; Hu Y; Pang Z; Jiang X
    Biomaterials; 2013 Dec; 34(36):9171-82. PubMed ID: 24008043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly efficacious and specific anti-glioma chemotherapy by tandem nanomicelles co-functionalized with brain tumor-targeting and cell-penetrating peptides.
    Zhu Y; Jiang Y; Meng F; Deng C; Cheng R; Zhang J; Feijen J; Zhong Z
    J Control Release; 2018 May; 278():1-8. PubMed ID: 29596873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual targeting effect of Angiopep-2-modified, DNA-loaded nanoparticles for glioma.
    Huang S; Li J; Han L; Liu S; Ma H; Huang R; Jiang C
    Biomaterials; 2011 Oct; 32(28):6832-8. PubMed ID: 21700333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioma targeting and blood-brain barrier penetration by dual-targeting doxorubincin liposomes.
    Gao JQ; Lv Q; Li LM; Tang XJ; Li FZ; Hu YL; Han M
    Biomaterials; 2013 Jul; 34(22):5628-39. PubMed ID: 23628475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of multifunctional peptide collaborated and docetaxel loaded lipid nanoparticles for antiglioma therapy.
    Kadari A; Pooja D; Gora RH; Gudem S; Kolapalli VRM; Kulhari H; Sistla R
    Eur J Pharm Biopharm; 2018 Nov; 132():168-179. PubMed ID: 30244167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model.
    Lakkadwala S; Singh J
    Colloids Surf B Biointerfaces; 2019 Jan; 173():27-35. PubMed ID: 30261346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.